["{\n\"step_by_step_thinking\": \"The patient has an elevated MSAFP level at 16 weeks' gestation. According to the documents, elevated MSAFP levels are often associated with large structural fetal anomalies or fetal death before 20 weeks. Since the patient is not certain about the date of her last menstrual period and is likely to have conceived shortly after stopping oral contraceptives, we cannot exclude the possibility of a major fetal anomaly. Therefore, the next step in management should be ultrasound evaluation.\",\n\"answer_choice\": \"C\"\n}"]